A lab run by blood-testing firm Theranos in Arizona put patients at risk and failed to quickly fix its deficiencies, a regulator found, triggering a new round of sanctions by the U.S. agency against the company.
from WSJ.com: US Business http://ift.tt/2mbY4EO
via IFTTT
No comments:
Post a Comment